| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 126.37 | 5.2% | 24.6% |
| Total Income | 128.00 | 5.3% | 24.3% |
| Expenditure | 112.14 | 3.0% | 29.5% |
| PBT | 15.86 | 24.4% | 3.1% |
| Net Profit | 14.57 | 55.5% | 13.0% |
| OPM | 18.49% | 1.26pp | 1.91pp |
| NPM | 11.38% | 3.67pp | 1.14pp |
| EPS | 1.78 | 56.1% | 13.4% |
GPT Healthcare Q4FY26 Revenue up 24.3% to ₹128 Cr; PAT up 13%
18 May 2026 · 18 May, 6:42 pm
Summary
GPT Healthcare Limited reported a strong performance for Q4FY26, with total revenue growing 24.30% year-on-year to ₹128.0 crore. Full-year FY26 revenue also saw a healthy increase of 15.14% to ₹478.5 crore. While Q4FY26 Profit After Tax (PAT) rose by 13.00% to ₹14.7 crore, the full-year PAT for FY26 decreased by 15.43% to ₹42.2 crore. Chairman Dr. Om Tantia highlighted disciplined execution, improving operating metrics, and broad-based growth across facilities, emphasizing the company's focus on affordability and clinical leadership.
Key Highlights
- 1
GPT Healthcare's total revenue for Q4FY26 increased by 24.30% year-on-year to ₹128.0 crore.
- 2
For the full financial year 2026, total revenue reached ₹478.5 crore, marking a 15.14% year-on-year growth.
- 3
Profit After Tax (PAT) for Q4FY26 was ₹14.7 crore, up 13.00% year-on-year, while FY26 PAT declined by 15.43% to ₹42.2 crore.
- 4
The company maintained a competitive ARPOB at ₹39,243 for FY26 and achieved an occupancy rate of 55.90% (excluding the newly commenced Raipur facility).
- 5
EBITDA for FY26 stood at ₹90.1 crore, showing a slight decrease of 1.86% year-on-year, with an EBITDA margin of 18.84%.
- 6
Significant operational developments include the successful commencement of the Raipur Hospital and signing an MoU for a 150-bed Jamshedpur Hospital targeted for commissioning by end of FY27.
- 7
The company also completed over 800 robotic surgeries at ILS Salt Lake, strengthening its advanced minimally invasive care offerings.
Management Comments
Dr. Om Tantia
GPT Healthcare delivered another quarter of strong and consistent performance, underpinned by disciplined execution, improving operating metrics, and broad-based growth across both mature hospitals and newer facilities. Network occupancy improved during the quarter, supported by higher patient volumes, enhanced throughput, and a stronger specialty mix, while ARPOB recorded year-on-year growth, with ARPOB for FY26 at ₹39,243, aligned with our strategy of serving the aspirational middle- to high-income population while maintaining affordability. The payer mix remained predominantly cash and insurance, reflecting revenue quality and financial resilience. We continued to strengthen our clinical and technological leadership, completing over 800+ robotic surgeries at ILS Salt Lake, reinforcing our position in advanced minimally invasive care, and commissioning the CTVS (Cardiothoracic and Vascular Surgery) in ILS-Dum Dum, ensuring complete cardiac care being provided under one roof.
Informational and educational content only. Not investment advice.